| Active ingredients | Dosage form | Quantity of active ingredients | Availability | Reason | Last updated |
| valaciclovir | Tablet, film coated | 500 mg | Limited Availability | Manufacturing | 11/07/2025 |
| losartan potassium | Tablet, film coated | 50 mg | Limited Availability | Manufacturing | 11/07/2025 |
| losartan potassium | Tablet, film coated | 25 mg | Limited Availability | Manufacturing | 11/07/2025 |
| risperidone | Tablet, film coated | 2 mg | Available | Manufacturing | 11/07/2025 |
| pioglitazone hydrochloride | Tablet | 16.63 mg | Available | Manufacturing | 11/07/2025 |
| risedronate sodium hemipentahydrate | Tablet, film coated | 173.4 mg | Limited Availability | Manufacturing | 11/07/2025 |
| phenobarbital | Tablet, uncoated | 30 mg | Available | Manufacturing | 11/07/2025 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Available | Unexpected increase in consumer demand | 11/07/2025 |
| bosentan monohydrate | Tablet, film coated | 129.082 mg | Limited Availability | Manufacturing | 11/07/2025 |
| pemetrexed disodium | Injection, powder for | 110.28 mg | Unavailable | Manufacturing | 11/07/2025 |
| pemetrexed disodium | Injection, powder for | 1102.8 mg | Unavailable | Manufacturing | 11/07/2025 |
| citalopram hydrobromide | Tablet, film coated | 12.495 mg | Limited Availability | Manufacturing | 11/07/2025 |
| daptomycin | Injection, powder for | 350 mg | Available | Manufacturing | 11/07/2025 |
| sodium lactate~icodextrin~calcium chloride dihydrate~magnesium chloride hexahydrate~sodium chloride | Solution, dialysis | 4.5 g/L~75 g/L~257 mg/L~51 mg/L~5.4 g/L | Limited Availability | Manufacturing | 11/07/2025 |
| methylphenidate hydrochloride | Tablet, uncoated | 10 mg | Available | Manufacturing | 10/07/2025 |
| ethinylestradiol~dienogest | Tablet, sugar coated | .03 mg~2 mg | Available | Commercial Changes / Commercial viability | 10/07/2025 |
| fludarabine phosphate | Injection, powder for | 50 mg | Unavailable | Manufacturing | 10/07/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Limited Availability | Manufacturing | 10/07/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Available | Manufacturing | 10/07/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Limited Availability | Unexpected increase in consumer demand | 10/07/2025 |
| tramadol hydrochloride | Tablet, modified release | 200 mg | Limited Availability | Manufacturing | 10/07/2025 |
| anastrozole | Tablet, film coated | 1 mg | Available | Manufacturing | 10/07/2025 |
| cefuroxime axetil | Tablet, film coated | 300.715 mg | Available | Manufacturing | 10/07/2025 |
| pegaspargase | Solution, powder for | 750 U/mL | Available | Manufacturing | 10/07/2025 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 41.363 mg~10 mg | Available | Manufacturing | 10/07/2025 |
| dimethyl fumarate | Capsule, enteric | 120 mg | Unavailable | Manufacturing | 10/07/2025 |
| lurasidone hydrochloride | Tablet, film coated | 40 mg | Unavailable | Manufacturing | 10/07/2025 |
| Albumin | Injection | .3 mg/mL | Unavailable | Manufacturing | 10/07/2025 |
| midazolam maleate | Solution | 10.2 mg | Limited Availability | Manufacturing | 10/07/2025 |
| rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 41.6 mg~10 mg | Limited Availability | Manufacturing | 10/07/2025 |
| Peginterferon alfa2a | Injection, solution | 135 microgram | Limited Availability | Unexpected increase in consumer demand | 10/07/2025 |
| Peginterferon alfa2a | Injection, solution | 180 microgram | Unavailable | Unexpected increase in consumer demand | 10/07/2025 |
| olanzapine pamoate monohydrate | Injection, powder for | 483 mg | Limited Availability | Transport / Logistic issues / Storage capacity issues | 9/07/2025 |
| methotrexate | Tablet, uncoated | 2.5 mg | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 9/07/2025 |
| artemether~lumefantrine | Tablet, dispersible | 20 mg~120 mg | Unavailable | Commercial Changes / Commercial viability | 9/07/2025 |
| riluzole | Tablet, film coated | 50 mg | Limited Availability | Manufacturing | 9/07/2025 |
| ondansetron | Tablet, orally disintegrating | 8 mg | Available | Manufacturing | 9/07/2025 |
| betamethasone dipropionate~calcipotriol | Foam | 264 microgram/g~20.5 microgram/g | Limited Availability | Transport / Logistic issues / Storage capacity issues | 9/07/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Unavailable | Manufacturing | 9/07/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Unavailable | Manufacturing | 9/07/2025 |
| paclitaxel | Injection, powder for | 100 mg | Limited Availability | Manufacturing | 9/07/2025 |
| desvenlafaxine | Tablet, modified release | 100 mg | Available | Manufacturing | 9/07/2025 |
| permethrin | Cream | 50 mg/g | Limited Availability | Commercial Changes / Commercial viability | 9/07/2025 |
| galantamine~galantamine hydrobromide | Capsule, modified release | 16 mg~20.51 mg | Available | Unexpected increase in demand due to other sponsors unable to supply | 9/07/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Available | Unexpected increase in consumer demand | 8/07/2025 |
| morphine sulfate pentahydrate | Tablet, modified release | 10 mg | Unavailable | Manufacturing | 8/07/2025 |
| morphine sulfate pentahydrate | Tablet, modified release | 30 mg | Unavailable | Manufacturing | 8/07/2025 |
| morphine sulfate pentahydrate | Tablet, modified release | 60 mg | Unavailable | Manufacturing | 8/07/2025 |
| morphine sulfate pentahydrate | Tablet, modified release | 100 mg | Unavailable | Manufacturing | 8/07/2025 |
| amiodarone hydrochloride | Injection, solution | 150 mg | Available | Unexpected increase in demand due to other sponsors unable to supply | 8/07/2025 |
| indapamide hemihydrate | Tablet, sugar coated | 2.5 mg | Available | Manufacturing | 8/07/2025 |
| nicorandil | Tablet | 10 mg | Unavailable | Manufacturing | 8/07/2025 |
| paclitaxel | Injection, concentrated | 300 mg | Limited Availability | Manufacturing | 8/07/2025 |
| calcipotriol~betamethasone dipropionate | Ointment | 52.2 microgram/g~643 microgram/g | Available | Manufacturing | 8/07/2025 |
| sodium valproate | Injection, solution | 400 mg | Available | Manufacturing | 8/07/2025 |
| estradiol~estradiol~norethisterone acetate | Drug delivery system, transdermal | .78 mg~.62 mg~2.7 mg | Unavailable | Manufacturing | 8/07/2025 |
| levothyroxine sodium | Tablet | 75 microgram | Unavailable | Manufacturing | 8/07/2025 |
| prazosin hydrochloride | Tablet, uncoated | 5.5 mg | Unavailable | Manufacturing | 8/07/2025 |
| prucalopride succinate | Tablet, film coated | 2.642 mg | Unavailable | Transport / Logistic issues / Storage capacity issues | 7/07/2025 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Unavailable | Manufacturing | 7/07/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Unavailable | Manufacturing | 7/07/2025 |
| deoxycholic acid | Injection, solution | 10 mg/mL | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/07/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Unavailable | Unexpected increase in consumer demand | 7/07/2025 |
| nicorandil | Tablet, uncoated | 10 mg | Limited Availability | Manufacturing | 7/07/2025 |
| nitisinone | Tablet | 10 mg | Unavailable | Manufacturing | 7/07/2025 |
| nitisinone | Tablet | 5 mg | Limited Availability | Manufacturing | 7/07/2025 |
| avatrombopag maleate | Tablet, film coated | 23.6 mg | Available | Manufacturing | 7/07/2025 |
2025年7月14日